-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Unique Features of Luminex Technology
Author:
InnoModels Biotechnology
Release time:
2024-01-31
Pushing the boundaries of technological innovation and leading the way to a new era of multiplexed assays, InnoModels Biotechnology has once again introduced its highly regarded Luminex technology. This technology has emerged as a leader in biomedical research, clinical diagnostics and drug discovery, and its unique features provide researchers with unprecedented flexibility and efficiency.
The outstanding features of Luminex technology
1. Multi-analytical capabilities:
InnoModels Bio's Luminex technology stands out for its unique multi-analytical capabilities. The microbead technology enables the simultaneous detection of multiple biomarkers, enabling high-throughput analysis of complex biological samples. This feature enables researchers to obtain more comprehensive data in a single experiment, saving time and resources.
2. High sensitivity and accuracy:
Luminex technology is recognized for its superior sensitivity and accuracy. The fluorescent markers on the beads can be detected at very low concentrations, providing researchers with an extremely sensitive analytical tool to detect changes in trace biomarkers, which is important for early disease diagnosis and monitoring.
3. High throughput and rapidity:
Luminex technology enables high-throughput analysis and, through its automated processes, is able to process large numbers of samples in a short period of time. This provides an efficient solution for large-scale studies and clinical trials, enabling researchers to access large-scale data more quickly and advancing the scientific research process.
4. Diverse range of applications:
The technology is widely used in biomedical research, immunology, infection virus monitoring, cancer marker research and other fields. The diversity of applications provides researchers with the flexibility to adapt to different research needs.
5. Customized experimental design:
Luminex technology supports customized experimental design, allowing researchers to select the biomarkers to be tested according to the specific purpose of the study, thus better meeting the needs of individual experiments.

Scientific Applications and Future Prospects
1. Immunology research:
In the field of immunology, the multi-analysis capability of Luminex technology provides the possibility of simultaneous detection of multiple immune indicators such as inflammatory factors and cytokines, which is expected to provide more comprehensive data support for in-depth research on the immune mechanisms of diseases.
2. Drug development and clinical trials:
In drug development and clinical trials, the high throughput and rapidity of Luminex technology provides an efficient means of evaluating drug effects and monitoring biomarker changes in clinical trial participants.
3. Cancer marker studies:
Luminex technology also performs well in cancer marker studies, and is expected to provide more accurate molecular information for early diagnosis and treatment strategies for cancer.
Conclusion
With its excellent features, Luminex technology from InnoModels Biotechnology provides researchers with a new multidimensional assay tool to help life science research move into a deeper and broader field. With continuous upgrades and innovations, InnoModels Biotechnology is expected to continue to lead the development of Luminex technology, bringing more cutting-edge applications to biomedical research, clinical diagnostics and drug discovery.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd